| 000 | 01873nam a2200265 4500 | ||
|---|---|---|---|
| 001 | 108493 | ||
| 003 | DR-UNIBE | ||
| 005 | 20260211062557.0 | ||
| 008 | 250613b2021 en ||||| |||| 00| 0 eng d | ||
| 020 | _a9781108838573 | ||
| 040 |
_aBIBLIOTECA UNIBE _cBIBLIOTECA UNIBE _bspa _erda |
||
| 041 | _aeng | ||
| 082 | _a615 S781e 2021 | ||
| 100 |
_aStahl, Stephen Michael, _d1951- _eautor _9144978 |
||
| 245 |
_aStahl's essential psychopharmacology : _b neuroscientific basis and practical applications / _cStephen Michel Stahl |
||
| 250 | _aQuinta edición | ||
| 260 |
_aCambridge : _bCambridge University Press, _c2021 |
||
| 300 |
_axiv, 623 páginas : _bilustraciones |
||
| 490 | _aCambridge medicine | ||
| 505 | _a1. Chemical neurotransmission| 2. Transporters, receptors and enzymes as targets of psychopharmacological drug action| 3. Ion channels as targets of psychopharmacological drug action| 4. Psychosis, schizophrenia and the neurotransmitter networks dopamine, serotonin and glutamate| 5. Targeting dopamine and serotonin receptors for psychosis, mood and beyond: so-called 'antipsychotics'| 6. Mood disorders and the neurotransmitter networks norepinephrine and gamma amino butyric acid (gaba)| 7. Treatments for mood disorders: so-called 'antidepressants' and 'mood stabilizers'| 8. Anxiety, trauma and treatment| 9. Chronic pain and its treatment| 10. Disorders of sleep and wakefulness and their treatment: neurotransmitter networks for histamine and orexin| 11. Attention deficit hyperactivity disorder and its treatment| 12. Dementia: causes, symptomatic treatments and the neurotransmitter network acetylcholine| 13. Impulsivity, compulsivity and addiction | | ||
| 650 | 7 |
_aPsicofarmacología _2lemb |
|
| 700 |
_9144979 _aGrady, Meghan M. _eeditor asistente |
||
| 700 |
_aMuntner, Nancy _eilustrador _9144980 |
||
| 942 |
_2ddc _cBK |
||
| 999 |
_c113751 _d113751 |
||